SQI Diagnostics Inc., a life sciences company, develops and commercializes proprietary technologies and products for advanced multiplexing diagnostics in Canada. The company offers sqidworks diagnostic platform, a fully-automated microarray processing and analytical system; sqidlite benchtop diagnostic platform, a fully automated bench top microarray processing and analytical system; and sqid-X, a semi-automated bench-top platform. Its products are used in immunogenicity and bioanalysis, IVD and clinical, biomarkers, and assay development applications. SQI Diagnostics Inc. has a co-develop and licensing agreement with McMaster University Department of Engineering to develop chip technology for use in multi-array disease testing. The company was founded in 1999 and is headquartered in Toronto, Canada.
Industry, Sector and Symbol
Industry Diagnostics & Research
Sub-IndustryN/A
SectorMedical
Phone+1-416-6749500
Debt
Price-To-Earnings
Sales & Book Value
Annual SalesC$1.34 million
Profitability
Miscellaneous
Employees42
OptionableNot Optionable
SQI Diagnostics (CVE:SQD) Frequently Asked Questions
What is SQI Diagnostics' stock symbol?
SQI Diagnostics trades on the Canadian Venture Exchange (CVE) under the ticker symbol "SQD."
How were SQI Diagnostics' earnings last quarter?
SQI Diagnostics Inc. (CVE:SQD) announced its quarterly earnings data on Tuesday, December, 11th. The company reported ($0.01) EPS for the quarter. The business earned $0.56 million during the quarter. View SQI Diagnostics' Earnings History.
When is SQI Diagnostics' next earnings date?
Has SQI Diagnostics been receiving favorable news coverage?
Media stories about SQD stock have been trending somewhat positive this week, InfoTrie Sentiment reports. InfoTrie identifies positive and negative media coverage by monitoring more than six thousand news and blog sources in real-time. The firm ranks coverage of companies on a scale of -5 to 5, with scores nearest to five being the most favorable. SQI Diagnostics earned a media sentiment score of 1.6 on InfoTrie's scale. They also assigned news stories about the company a news buzz of 10.0 out of 10, indicating that recent media coverage is extremely likely to have an effect on the company's share price in the near future.
Who are some of SQI Diagnostics' key competitors?
Some companies that are related to SQI Diagnostics include 3D Signatures (DXD), BioNano Genomics (BNGOU), Cambridge Cognition (COG), Carl Data Solutions (CRL), Carl Zeiss Meditec (AFX), Co-Diagnostics (CODX), Deepmatter Group (DMTR), Dorsavi (DVL), EPIGENOMICS AG/S (EPGNY), Eternity Healthcare (ETAH), Genedrive (GDR), GeneNews (GEN), Imaging Dynamics (IDL), LED Medical Diagnostics (LMD) and Lexagene (LXG).
Who are SQI Diagnostics' key executives?
SQI Diagnostics' management team includes the folowing people:
- Mr. Andrew Morris, CEO, Pres & Director (Age 53)
- Ms. Patricia Lie CPA, CA, VP of Fin. & Admin.
- Dr. Peter Lea Ph.D., Founder (Age 74)
- Dr. Eric Brouwer, Chief Scientific Officer
- Mr. Russell Peloquin, VP of Global Commercial Operations
How do I buy shares of SQI Diagnostics?
Shares of SQD and other Canadian stocks can be purchased through online brokerage accounts that support trading on the Toronto Stock Exchange (TSX). Brokers that permit trading on the TSX include Fidelity, Interactive Brokers, PennTrade and Charles Schwab.
What is SQI Diagnostics' stock price today?
One share of SQD stock can currently be purchased for approximately C$0.08.
What is SQI Diagnostics' official website?
How can I contact SQI Diagnostics?
SQI Diagnostics' mailing address is 36 Meteor Dr, ETOBICOKE, ON M9W 1A4, Canada. The company can be reached via phone at +1-416-6749500.
MarketBeat Community Rating for SQI Diagnostics (CVE SQD)
MarketBeat's community ratings are surveys of what our community members think about SQI Diagnostics and other stocks. Vote "Outperform" if you believe SQD will outperform the S&P 500 over the long term. Vote "Underperform" if you believe SQD will underperform the S&P 500 over the long term. You may vote once every thirty days.
